U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07032649) titled 'Double-Blind, Placebo-Controlled Clinical Trial Evaluating Benzoyl Peroxide for Preventing Recurrence of HSV-1 Outbreaks With Rescue Crossover Option' on June 16.
Brief Summary: Here's a clear, concise, and accurate **brief summary** suitable for your ClinicalTrials.gov PRS submission:
* Brief Summary:
This randomized, double-blind, placebo-controlled clinical trial evaluates the effectiveness of topical Benzoyl Peroxide (10%) in preventing recurrent oral lesions caused by Herpes Simplex Virus Type 1 (HSV-1). Participants who experience frequent HSV-1 outbreaks will be randomly assigned to either Benzoyl Peroxide or placebo treatm...